Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Age-related macular degeneration (AMD) is the leading cause of vision loss in older adults in many parts of the world. It affects the macula — the central part of the

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience If your child or a family member has been diagnosed with Usher syndrome, you may have also come across the term “retinitis pigmentosa” (RP) in the same conversation. These two

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Eye injuries — whether from trauma, chemical exposure, burns, or surgical complications — can damage delicate structures like the cornea, retina, or optic nerve, sometimes leading to permanent vision loss.

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Retinobulbar injection is one of several delivery methods used in eye stem cell therapy, and patients considering this specific approach deserve a clear, detailed understanding of what the procedure actually

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience While Stargardt’s disease is often associated with childhood onset, a meaningful number of cases present later, in young adulthood — and these cases are frequently misdiagnosed or delayed in diagnosis,

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Choosing where to pursue eye stem cell treatment is a significant decision, and with the field growing rapidly, patients need a clear, practical framework for evaluating potential providers. Here are

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Rod and cone dystrophy refers to a group of inherited retinal conditions affecting the light-sensing photoreceptor cells in the retina, and patients newly diagnosed often have many questions about what

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience A diagnosis of optic nerve hypoplasia in a child brings both practical and deeply emotional questions for parents, and research into stem cell therapy as a potential option is understandably

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Glaucoma is often called the “silent thief of sight” because significant vision loss can occur before a person notices any symptoms – making understanding this condition genuinely important, not just